A hallmark of cancer is the avoidance of immune destruction. This process has been primarily…
karnottMarch 6, 2024
Type 2 diabetes (T2D) is a heterogeneous disease that develops through diverse pathophysiological processes1,2 and…
karnottMarch 4, 2024
Joseph P. Mizgerd, ScD, the Jerome S. Brody, MD, Professor of Pulmonary Medicine, and director…
karnottMarch 4, 2024
In a new Voices of UMass Chan podcast, physician-scientist John P. Haran, MD’07, PhD’18, and…
karnottMarch 1, 2024
Metazoan gene expression regulation involves pausing of RNA polymerase (Pol II) in the promoter-proximal region…
karnottMarch 1, 2024
Work from the lab of Jeeyun Chung, Assistant Professor of Molecular and Cellular Biology, on…
karnottFebruary 29, 2024
Successful immunotherapy for cancer involves activating a person’s own T cells to identify telltale proteins…
karnottFebruary 28, 2024
The phase III JAVELIN Renal 101 trial demonstrated prolonged progression-free survival (PFS) in patients (N = 886)…
karnottFebruary 28, 2024
In August 2008, Shamim Dahod (CGS’76, CAS’78, CAMED’87) and her husband Ashraf gave $10.5M to…
karnottFebruary 27, 2024
